PT1583768E - Processo de redução do teor de ferro em risedronato de sódio - Google Patents

Processo de redução do teor de ferro em risedronato de sódio Download PDF

Info

Publication number
PT1583768E
PT1583768E PT04702936T PT04702936T PT1583768E PT 1583768 E PT1583768 E PT 1583768E PT 04702936 T PT04702936 T PT 04702936T PT 04702936 T PT04702936 T PT 04702936T PT 1583768 E PT1583768 E PT 1583768E
Authority
PT
Portugal
Prior art keywords
risedronate sodium
reducing
iron
iron content
sodium
Prior art date
Application number
PT04702936T
Other languages
English (en)
Inventor
Revital Lifshitz-Liron
Rami Lidor-Hadas
Sasson Nissm
Igor Lifshitz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of PT1583768E publication Critical patent/PT1583768E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT04702936T 2003-01-17 2004-01-16 Processo de redução do teor de ferro em risedronato de sódio PT1583768E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44106203P 2003-01-17 2003-01-17
US44513903P 2003-02-05 2003-02-05

Publications (1)

Publication Number Publication Date
PT1583768E true PT1583768E (pt) 2008-09-11

Family

ID=32776044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04702936T PT1583768E (pt) 2003-01-17 2004-01-16 Processo de redução do teor de ferro em risedronato de sódio

Country Status (11)

Country Link
US (1) US7358360B2 (pt)
EP (1) EP1583768B1 (pt)
JP (2) JP3869456B2 (pt)
AT (1) ATE402942T1 (pt)
CA (1) CA2513543A1 (pt)
DE (1) DE602004015407D1 (pt)
ES (1) ES2311142T3 (pt)
IL (1) IL169569A (pt)
PL (1) PL377878A1 (pt)
PT (1) PT1583768E (pt)
WO (1) WO2004065397A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
EP1888606A2 (en) * 2005-05-28 2008-02-20 PLIVA HRVATSKA d.o.o. Process and novel salt
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
KR20090005206A (ko) 2006-05-11 2009-01-12 인드-스위프트 래버러토리즈 리미티드 순수한 리세드론산 또는 염의 제조 방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
CN101024654A (zh) 2002-04-11 2007-08-29 特瓦制药工业有限公司 利塞膦酸钠的新多晶型物和假多晶型物
US7645460B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate

Also Published As

Publication number Publication date
ES2311142T3 (es) 2009-02-01
EP1583768A1 (en) 2005-10-12
JP2006515867A (ja) 2006-06-08
JP2007008956A (ja) 2007-01-18
CA2513543A1 (en) 2004-08-05
IL169569A (en) 2010-04-29
ATE402942T1 (de) 2008-08-15
US20040192655A1 (en) 2004-09-30
EP1583768B1 (en) 2008-07-30
JP3869456B2 (ja) 2007-01-17
DE602004015407D1 (de) 2008-09-11
WO2004065397A1 (en) 2004-08-05
PL377878A1 (pl) 2006-02-20
US7358360B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
PT1583768E (pt) Processo de redução do teor de ferro em risedronato de sódio
MY148586A (en) Treatment fluids comprising diutan and associated methods
EP1229958A4 (en) METHOD AND DEVICES FOR REDUCING THE MINERAL CONTENT OF A ZONE OF NON-INTIMATE VASCULAR TISSUE
MY164311A (en) Process to remove impurities from triacylglycerol oil
HK1087133A1 (en) Method for producing aqueous dispersions
MY148921A (en) Enzymatic oil interesterification
MY141005A (en) Branched biodiesels
SG145635A1 (en) Methods for lubricating a transmission
AR002475A1 (es) Composicion liquida que comprende una enzima y un estabilizador enzimatico derivado del acido fenil-boronico.
MY150971A (en) Mineral amino acid polysaccharide complex
EP2114851A4 (en) METHOD FOR SEPARATING SATURATED AND UNSATURATED FATTY ACIDS
WO2007021617A3 (en) Dosage efficient, storage stable compositions for reducing chromium (vi) in cement
MY161356A (en) Compositions and methods for inhibiting emulsion formation in hydrocarbon bodies
TW200640496A (en) Visco-supplement composition and methods
TNSN05021A1 (en) Method and installation for the production of lime water from deionised water
TWI319385B (en) Injection grouting
BR0306699A (pt) Sistema de células de combustìvel, método para preparar uma emulsão bicontìnua, emulsão bicontìnua, método para prevenir corrosão de uma superfìcie metálica, e, composição
TW200626079A (en) Method of storing fragrant component
PE20040429A1 (es) Proceso para el beneficio de minerales sulfurados
MXPA05010837A (es) Aditivo para reducir la contraccion para composiciones de cemento.
MXPA05013595A (es) Proceso para aumentar la extraccion de liquido de las telas.
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
EP1791851A4 (en) PROCESS FOR THE PREPARATION OF ALKYL PHOSPHINATES
MY156956A (en) Method for producing vegetable oil
CN104403818B (zh) 一种石油泥砂清洗剂